EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 17 lipnja 2024. Database contains 4917 unique substances/entries.
Filter the list

 
500-024-6
9016-45-9
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
931-755-2
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
939-993-9
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
931-756-8
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
931-753-1
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
931-754-7
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
-
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
938-618-6
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
932-998-7
-
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
show/hide
Phenol, methylstyrenated EC / List no: 270-966-8 | CAS no: 68512-30-1
700-960-7
-
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
-
-
C Carcinogenic (article 57a)
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
P Parasites
Details
-
-
P Parasites
Details
-
-
P Parasites
Details
215-235-6
1314-41-6
R Toxic for reproduction (article 57c)
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
250-339-5
30784-30-6
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
201-280-9
80-46-6
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
241-427-4
17404-66-9
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
247-770-6
26543-97-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
203-199-4
104-40-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
-
-
F Fungi
Details
287-196-3
85422-92-0
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
307-202-0
97553-43-0
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
-
-
P Parasites
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
B Bacteria and similar species
Details
-
-
B Bacteria and similar species
Details
-
-
F Fungi
Details
276-745-2
72629-94-8
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
235-067-7
12065-90-6
R Toxic for reproduction (article 57c)
Details
256-418-0
49663-84-5
C Carcinogenic (article 57a)
Details
-
-
B Bacteria and similar species
Details
603-902-8
13517-20-9
R Toxic for reproduction (article 57c)
Details
600-611-8
10486-00-7
R Toxic for reproduction (article 57c)
Details
600-419-4
10332-33-9
R Toxic for reproduction (article 57c)
Details
234-390-0
11138-47-9;12040-72-1;37244-98-7
R Toxic for reproduction (article 57c)
Details
234-390-0
11138-47-9;12040-72-1;37244-98-7
R Toxic for reproduction (article 57c)
Details

Export search results to: